In silico analysis to identify novel ceRNA regulatory axes associated with gallbladder cancer

Competitive endogenous RNA (ceRNA) networks are reported to play a crucial role in regulating cancer-associated genes. Identification of novel ceRNA networks in gallbladder cancer (GBC) may improve the understanding of its pathogenesis and might yield useful leads on potential therapeutic targets for GBC. For this, a literature survey was done to identify differentially expressed lncRNAs (DELs), miRNAs (DEMs), mRNAs (DEGs) and proteins (DEPs) in GBC. Ingenuity pathway analysis (IPA) using DEMs, DEGs and DEPs in GBC identified 242 experimentally observed miRNA-mRNA interactions with 183 miRNA targets, of these 9 (CDX2, MTDH, TAGLN, TOP2A, TSPAN8, EZH2, TAGLN2, LMNB1, and PTMA) were reported at both mRNA and protein levels. Pathway analysis of 183 targets revealed p53 signaling among the top pathway. Protein-protein interaction (PPI) analysis of 183 targets using the STRING database and cytoHubba plug-in of Cytoscape software revealed 5 hub molecules, of which 3 of them (TP53, CCND1 and CTNNB1) were associated with the p53 signaling pathway. Further, using Diana tools and Cytoscape software, novel lncRNA-miRNA-mRNA networks regulating the expression of TP53, CCND1, CTNNB1, CDX2, MTDH, TOP2A, TSPAN8, EZH2, TAGLN2, LMNB1, and PTMA were constructed. These regulatory networks may be experimentally validated in GBC and explored for therapeutic applications.

[1]  R. Sirdeshmukh,et al.  Quantitative tissue proteome profile reveals neutrophil degranulation and remodeling of extracellular matrix proteins in early stage gallbladder cancer , 2023, Frontiers in Oncology.

[2]  Kecheng Zhang,et al.  Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma , 2022, iScience.

[3]  Jian Xu,et al.  The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer , 2022, Cell Death Discovery.

[4]  Xiaoyan Yu,et al.  LncRNA TUG1 functions as a ceRNA for miR‐1‐3p to promote cell proliferation in hepatic carcinogenesis , 2022, Journal of clinical laboratory analysis.

[5]  Chen Huang,et al.  Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR‐30a to regulate COX‐2/BCL9 pathway , 2021, Helicobacter.

[6]  Yiming Zhao,et al.  Long noncoding RNA MALAT1 sponging miR-26a-5p to modulate Smad1 contributes to colorectal cancer progression by regulating autophagy. , 2021, Carcinogenesis.

[7]  S. Mahati,et al.  The Tumorigenic Properties of EZH2 are Mediated by MiR-26a in Uveal Melanoma , 2021, Frontiers in Molecular Biosciences.

[8]  Yuchen Gao,et al.  miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2 , 2021, BioMed research international.

[9]  H. Shiraha,et al.  Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients , 2021, Scientific Reports.

[10]  Guangsheng Wang,et al.  LncRNA MALAT1 Promote Cell Proliferation and Invasion by Sponging miR-125b to Modulate HMGA1 Expression in Laryngocarcinoma , 2021, Iranian journal of public health.

[11]  I. Santin,et al.  The Role of lncRNAs in Gene Expression Regulation through mRNA Stabilization , 2021, Non-coding RNA.

[12]  Tao Zhang,et al.  Knockdown of Long Noncoding RNA Urothelial Carcinoma-Associated 1 Represses Gallbladder Cancer Advancement by Regulating SPOCK1 Expression Through Sponging miR-613. , 2020, Cancer biotherapy & radiopharmaceuticals.

[13]  Jing Wu,et al.  Survival analysis of patients with primary gallbladder cancer from 2010 to 2015 , 2020, Medicine.

[14]  Huihui Guo,et al.  MicroRNA-195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway , 2020, International journal of molecular medicine.

[15]  Weijian Guo,et al.  EZH2: a novel target for cancer treatment , 2020, Journal of Hematology & Oncology.

[16]  Jiangman Zhao,et al.  RNA Sequencing Revealed Signals of Evolution From Gallbladder Stone to Gallbladder Carcinoma , 2020, Frontiers in Oncology.

[17]  Ling-Juan Jin,et al.  Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis , 2020, Molecular and Cellular Biochemistry.

[18]  Y. Qiu,et al.  Long Noncoding RNA NEAT1 Upregulates Survivin and Facilitates Gallbladder Cancer Progression by Sponging microRNA-335 , 2020, OncoTargets and therapy.

[19]  Zhen-bo Feng,et al.  Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1 , 2020, PeerJ.

[20]  Chen Chen,et al.  LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis , 2019, Molecular Cancer.

[21]  Artemis G. Hatzigeorgiou,et al.  DIANA-LncBase v3: indexing experimentally supported miRNA targets on non-coding transcripts , 2019, Nucleic Acids Res..

[22]  L. Tian,et al.  Taurine up-regulated 1 accelerates tumorigenesis of colon cancer by regulating miR-26a-5p/MMP14/p38 MAPK/Hsp27 axis in vitro and in vivo. , 2019, Life sciences.

[23]  L. Kong,et al.  Identification of messenger and long noncoding RNAs associated with gallbladder cancer via gene expression profile analysis , 2019, Journal of cellular biochemistry.

[24]  Z. Shao,et al.  Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor-κB signaling pathway , 2019, Molecular medicine reports.

[25]  C. Pérez-Plasencia,et al.  Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer , 2019, Front. Oncol..

[26]  Y. Dang,et al.  MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1 , 2019, Cancer management and research.

[27]  Fei Li,et al.  MALAT1 regulates miR-34a expression in melanoma cells , 2019, Cell Death & Disease.

[28]  J. Bergquist,et al.  Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB) , 2019, Clinical Proteomics.

[29]  Man-Tzu Wang,et al.  The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling , 2019, Yonsei medical journal.

[30]  P. Schirmacher,et al.  Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p , 2019, Scientific Reports.

[31]  Shuquan Wei,et al.  LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis , 2019, International journal of immunopathology and pharmacology.

[32]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[33]  P. Lin,et al.  Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma , 2018, Cellular Physiology and Biochemistry.

[34]  Li‐Juan Xu,et al.  Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  Gang Chen,et al.  The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA , 2018, Cellular Physiology and Biochemistry.

[36]  Zhipeng You,et al.  MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9 , 2018, Experimental and therapeutic medicine.

[37]  Wanhu Li,et al.  The LncRNA H19/miR‐193a‐3p axis modifies the radio‐resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1 , 2018, Journal of cellular biochemistry.

[38]  Cuilan Wang,et al.  miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2 , 2018, Archives of Gynecology and Obstetrics.

[39]  Guoqiang Zhao,et al.  MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer , 2017, Oncotarget.

[40]  Yang Cao,et al.  LncRNA‐PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis , 2017, EMBO reports.

[41]  Han Liu,et al.  Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis , 2017, Oncology letters.

[42]  Zhuo-wei Hu,et al.  The regulation of β-catenin activity and function in cancer: therapeutic opportunities , 2017, Oncotarget.

[43]  Ying Zhang,et al.  Long non-coding RNA TUG1 promotes endometrial cancer development via inhibiting miR-299 and miR-34a-5p , 2017, Oncotarget.

[44]  Xiaoming Jin,et al.  The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing β-Catenin Expression in Colorectal Cancer , 2017, BioMed research international.

[45]  Donghui Zheng,et al.  Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195 , 2016, Oncotarget.

[46]  Zhaohui Tang,et al.  Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer , 2016, Journal of experimental & clinical cancer research : CR.

[47]  Shouhua Wang,et al.  Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. , 2016, Cancer letters.

[48]  X. Kong,et al.  Long Noncoding RNA GCASPC, a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase-Dependent Cell Proliferation in Gallbladder Cancer. , 2016, Cancer research.

[49]  Chung-Yen Lin,et al.  cytoHubba: identifying hub objects and sub-networks from complex interactome , 2014, BMC Systems Biology.

[50]  W. Guo,et al.  MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer , 2014, Cancer science.

[51]  Yi Wang,et al.  Proteomic identification of tumor biomarkers associated with primary gallbladder cancer. , 2014, World journal of gastroenterology.

[52]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[53]  X. Zhao,et al.  MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways , 2013, British Journal of Cancer.

[54]  N. Seki,et al.  Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. , 2012, International journal of oncology.

[55]  K. Ranganathan,et al.  Expression of p53 and Cyclin D1 in oral squamous cell carcinoma and normal mucosa: An Immunohistochemical study , 2012, Journal of oral and maxillofacial pathology : JOMFP.

[56]  A. Zhu,et al.  Current management of gallbladder carcinoma. , 2010, The oncologist.

[57]  Yubo Xie,et al.  Overexpression of Cdx2 inhibits progression of gastric cancer in vitro. , 2009, International journal of oncology.

[58]  H. Lodish,et al.  MicroRNA-125b is a novel negative regulator of p53. , 2009, Genes & development.

[59]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[60]  S. Choi,et al.  Gene Expression Profiles in Gallbladder Cancer: The Close Genetic Similarity Seen for Early and Advanced Gallbladder Cancers May Explain the Poor Prognosis , 2008, Tumor Biology.

[61]  Yuman Fong,et al.  Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract , 2008, Journal of experimental & clinical cancer research : CR.

[62]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[63]  Raymond L. White,et al.  Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. , 2001, Molecular cell.

[64]  S. Lowe,et al.  Apoptosis in cancer. , 2000, Carcinogenesis.

[65]  I. D. Sharma,et al.  Overexpression of p53 protein in gallbladder carcinoma in North India. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[66]  X. Kong,et al.  Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway. , 2019, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

[67]  Jié He,et al.  Constitutive activation of STAT3 and cyclin D1 overexpression contribute to proliferation, migration and invasion in gastric cancer cells. , 2017, American journal of translational research.

[68]  S. Gunduz,et al.  Prognostic significance of p53 in gastric cancer: a meta- analysis. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[69]  J. Roa,et al.  miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer. , 2014, International journal of clinical and experimental pathology.

[70]  P. Sakhuja,et al.  p53 and Beta-Catenin Expression in Gallbladder Tissues and Correlation with Tumor Progression in Gallbladder Cancer , 2013, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[71]  X. Bian,et al.  miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. , 2010, Biochemical and biophysical research communications.